4 Best Cannabis Stocks Under $10

One of the best reasons to buy low-priced stocks is they often have more room to rise in value than higher-priced stocks, especially in the fast-growing cannabis industry. They can also be more liquid, since investors won’t be put off by the idea of owning just one or two shares, or even just a fraction of a share. Priced at $10 or less, you could…

own 10 shares of a company with a modest $100 investment. With $1,000, you could own 100 shares or more.

Four of the best cannabis stocks that you can buy today at less than $10 are Cresco Labs (OTC:CRLBF)Village Farms (NASDAQ:VFF)Tilray (NASDAQ:TLRY), and Curaleaf (OTC:CURLF). The marijuana industry is still in its early growth stages, and these stocks could position you for some great returns later on. Here’s why each of these stocks is an attractive buy today.

1. Cresco Labs

Chicago-based Cresco Labs is experiencing exciting sales growth, after Illinois legalized adult-use marijuana in 2019. The Illinois Department of Revenue has already collected more than $100 million in tax revenue from the recreational marijuana market. Posting record-breaking sales month after month has been the norm for the state, which reported recreational sales of $67.6 million in September — up from $39.2 million in January. And Cresco Labs is in a great position to benefit from the new market, with nine locations in Illinois and a 10th in the works. If you’re looking for a stock that can benefit from the state’s explosive growth, Cresco is certainly it. (The company even has a strategic dispensary located near Wrigley Field.)

Through the first six months of 2020, Cresco’s sales totaled $160.6 million — more than triple the $50.9 million that it generated during the same period last year. The company has been growing thanks to a combination of acquisitions (including Origin House, which it closed earlier this year) and organic growth in its existing operations. And with a variety of different brands available, Cresco is able to meet the needs of a wide cross-section of cannabis consumers, including those looking for premium products, edibles, and medical products. Today, the stock trades around $7.50 and is up 10% year to date.

2. Village Farms

Village Farms is an appealing investment because the British Columbia-based company recently took complete ownership of Pure Sunfarms, a low-cost cannabis producer. Previously, Village Farms owned a portion of Pure Sunfarms through a joint venture with Emerald Therapeutics. Today, it owns 100% of the greenhouse, having bought out Emerald’s holdings in September for 79.9 million Canadian dollars.

For the first two quarters of 2020, Pure Sunfarms contributed just under $4 million to Village Farms’ bottom line. In its most recent quarterly results, released on Aug. 12 for the period through the end of June, Village Farms’ ownership of Pure Sunfarms was just 58.7%. With a greater stake in the greenhouse, Village Farms will stand to benefit even more from its efficient operations. In the six-month period ended June 30, Pure Sunfarms generated net income of $7 million — 31% of its net sales. Village Farms reported a profit of $4.1 million over the same period, the bulk of which was due to Pure Sunfarms.

With a greater share of Pure Sunfarms, Village Farms is in a solid position to achieve profitability in future quarters (it’s only posted a profit once in its last four quarters), which could make it a bargain buy at a price of around $5 today. Its year-to-date sales (excluding Pure Sunfarms) total $79.7 million and have grown 9% from the same period last year. On its own, Village Farms wouldn’t be all that exciting of an investment. But with Pure Sunfarms secured, Village Farms is a hot buy. Year to date, shares of Village Farms are down 15%.

3. Tilray

British Columbia-based Tilray has more diversified business operations than your typical cannabis stock. Tilray released quarterly results on Aug. 10. Its year-to-date sales of $102.5 million grew an impressive 49% year over year. Its cannabis sales of $60.9 million rose 40% from the prior-year period, and hemp revenue climbed 63% to $41.6 million. For the quarter ended June 30, Tilray’s hemp sales of…

Continue reading at THE MOTLEY FOOL



You May Also Like

About the Author: admin

Leave a Reply

Your email address will not be published.